Search research articles
Contact Us
Filters
Showing results (141-150 of 180) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up
S De Placido, C Carlomagno, F Ciardiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides
N Normanno, C Bianco, V Damiano, et al.
British Journal of Cancer
|
April 11, 2013
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V Damiano, R Rosa, L Formisano, et al.
British Journal of Cancer
|
September 25, 2025
Retraction Note: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V Damiano, R Rosa, L Formisano, et al.
British Journal of Cancer
|
August 21, 2015
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
G Piro, S Giacopuzzi, M Bencivenga, et al.
Respiratory Research
|
August 27, 2016
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations
U Peretti, R Ferrara, S Pilotto, et al.
Oncology Reports
|
May 25, 2011
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
P Tagliaferri, P Correale, M Mottola, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Fertility and sexuality in early-onset colorectal cancer patients: a monocentric survey
A Spring, M A Calegari, G Valente, et al.
Prostate Cancer and Prostatic Diseases
|
January 19, 2005
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease
G Di Lorenzo, S De Placido, R Autorino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2011
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
C Gridelli, F Morgillo, A Favaretto, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 180) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up
S De Placido, C Carlomagno, F Ciardiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides
N Normanno, C Bianco, V Damiano, et al.
British Journal of Cancer
|
April 11, 2013
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V Damiano, R Rosa, L Formisano, et al.
British Journal of Cancer
|
September 25, 2025
Retraction Note: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V Damiano, R Rosa, L Formisano, et al.
British Journal of Cancer
|
August 21, 2015
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
G Piro, S Giacopuzzi, M Bencivenga, et al.
Respiratory Research
|
August 27, 2016
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations
U Peretti, R Ferrara, S Pilotto, et al.
Oncology Reports
|
May 25, 2011
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
P Tagliaferri, P Correale, M Mottola, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Fertility and sexuality in early-onset colorectal cancer patients: a monocentric survey
A Spring, M A Calegari, G Valente, et al.
Prostate Cancer and Prostatic Diseases
|
January 19, 2005
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease
G Di Lorenzo, S De Placido, R Autorino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2011
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
C Gridelli, F Morgillo, A Favaretto, et al.
Page
of 18